Goserelin acetate (Zoladex) with or without hormone replacement therapy for the treatment of endometriosis

Fertility and Sterility

Volumn 69, Issue 6, 1998, Pages 1056-1062

  Moghissi, Kamran S ^a   Schlaff, William D ^b   Olive, David L ^b   Skinner, Michael A ^b   Yin, Helen ^b  

^a HUTZEL HOSPITAL   (United States)

^b NONE

Author keywords

Endometriosis; Estrogen; GnRH a; Hormonal add back therapy; Progestogen; Zoladex

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; GOSERELIN; MEDROXYPROGESTERONE ACETATE; PROGESTERONE;

ADULT; ARTICLE; BONE MINERAL; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DYSMENORRHEA; DYSPAREUNIA; ENDOMETRIOSIS; FEMALE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OSTEOPOROSIS; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; XEROSIS;

ADOLESCENT; ADULT; BONE DENSITY; DOUBLE-BLIND METHOD; ENDOMETRIOSIS; ESTROGEN REPLACEMENT THERAPY; FEMALE; GOSERELIN; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; PELVIS; PROSPECTIVE STUDIES;

EID: 0032101238     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00086-7     Document Type: Article

References (14)

1. 1. Lemay A, Maheux R, Faure N, Jean C, Fazekas ATA. Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LHRH) agonist (Buserelin) as a new therapeutic approach for endometriosis. Fertil Steril 1984;41:863-71.
2. 2. Erickson LD, Ory SJ. GnRH analogues in the treatment of endometriosis. Obstet Gynecol Clin North Am 1989;16:23-45.
3. 3. Henzl MR, Corson SL, Moghissi K, Buttram VC, Bergvist C, Jacobson J. Administration of nasal nafarelin as compared with oral danazol for endometriosis: a multicentre double-blind comparative trial. N Engl J Med 1988;318:485-9.
4. 4. Rock JA, Truglia JA, Caplan RJ, Zoladex Endometriosis Study Group. Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. Obstet Gynecol 1993;82:198-205.
5. 5. Surrey E. Steroidal and nonsteroidal "add-back" therapy: extending safety and efficacy of gonadotropin-releasing hormone agonists in the gynecology patients. Fertil Steril 1995;64:673-85.
6. 6. Barbieri R. Hormone treatment of endometriosis: the estrogen threshold hypothesis. Am J Obstet Gynecol 1992;166:740-5.
7. 7. Lemay A, Dodin S, Dewailly S. Long-term use of the low dose LHRH analogue combined with monthly medroxy-progesterone administration. Horm Res 1989;32 Suppl 1:141-5.
8. 8. Cedars M, Lu J, Meldrum D, Judd H. Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate. Obstet Gynecol 1990;5:641-5.
9. 9. Riis B, Christiansen C, Johansen J, Jacobson J. Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists? J Clin Endocrinol Metab 1990;70:920-4.
10. 10. Surrey E, Judd H. Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. J Clin Endocrinol Metab 1992;75: 558-63.
11. 11. Eldred J, Haynes P, Thomas C. A randomized double-blind placebo controlled trial of the effects of bone metabolism of the combination of nafarelin acetate and norethisterone. Clin Endocrinol (Oxf) 1992;37: 354-9.
12. 12. Howell R, Edmonds DK, Dowsett M, Cook D, Lees B, Stevenson JE. Gonadotropin releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized control trial. Fertil Steril 1995;64:474-81.
13. 13. Kiilholma P, Tuimala R, Kivinen S, Korhonen M, Hagman E. Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis. Fertil Steril 1995;64: 903-8.
14. 14. The American Fertility Society. Revised American Fertility Society classification of endometriosis; 1985. Fertil Steril 1985;43:351-2.